Clinical relevance of thymic and bone marrow outputs in multiple sclerosis patients treated with alemtuzumab.
Sottini A, Quaresima V, Barbaro M, Moiola L, Filippi M, Malentacchi M, Capobianco M, Puthenparampil M, Gallo P, Cocco E, Frau J, Zaffaroni M, Guaschino C, Stampatori C, Mancinelli C, Brambilla L, Clerici VT, Vianello M, Vitetta F, Ferraro D, Rosettani P, Danni MC, Conti M, Grimoldi M, Capra R, Imberti L.
Sottini A, et al. Among authors: rosettani p.
J Neuroimmunol. 2023 Sep 15;382:578170. doi: 10.1016/j.jneuroim.2023.578170. Epub 2023 Aug 7.
J Neuroimmunol. 2023.
PMID: 37579546
Free article.